chevron_leftBack
V
As of 13 June 2026, Veraxa Biotech AG has a market cap of $632.5M USD, ranking #13592 globally and #151 in Switzerland.
It ranks #1219 in the Healthcare sector, and #453 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$632.5MUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -19% | 7.2% | 7.2% | 7.2% | 7.2% | 7.2% |
News
Loading...
VRXA Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
VRXA
ISIN: CH1476899161
Shares Out.:
Shares Outstanding:
25.3M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
20.00 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SIX: RO
|
$321.52B
51K%
256.25B CHF
|
19.9
|
|
SIX: NOVN
|
$274.65B
43K%
218.9B CHF
|
20.5
|
|
SIX: GALD
|
$46.58B
7K%
37.12B CHF
|
77.4
|
|
SIX: SDZ
|
$34.02B
5K%
27.11B CHF
|
37.8
|
|
SSE: 688235
|
$32.61B
5K%
220.98B CNY
|
110.1
|
|
SIX: BANB
|
$6.41B
913%
5.11B CHF
|
34.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
120K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
86K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
57K%
|
97.4
|
|
LSE: AZN
|
$288.84B
46K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
43K%
|
15.1
|
|
CPH: NOVO-B
|
$181.82B
29K%
1.18T DKK
|
11.5
|
chevron_leftBack